Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2017Scientific ReportsOpen Access

The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

ZLZhengtao LiuChinese Academy of Medical Sciences & Peking Union Medical CollegeLZLin ZhouSir Run Run Shaw HospitalSZShusen ZhengShanghai Medical College of Fudan University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2017) studied this question.

synapsesocial.com/papers/6aa8e7e32ed5bb30c9299994https://doi.org/10.1038/s41598-017-09548-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1New horizons in hepatitis C antiviral therapy with direct-acting antivirals2013 · 155 citations
  2. 2Prognosis of Chronic Hepatitis C: Results of A Large, Prospective Cohort Study1998 · 641 citations
  3. 3Steatosis Accelerates the Progression of Liver Damage of Chronic Hepatitis C Patients and Correlates With Specific Hcv Genotype and Visceral Obesity2001 · 1,064 citations
  4. 4Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases2014 · 181 citations
  5. 5Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol2002 · 358 citations